This post was originally published on this site
A customer gets help from an employee at a Best Buy store in San Francisco.
David Paul Morris | Bloomberg | Getty Images
Best Buy‘s “underrated” step into health care could dramatically grow the company’s revenue and stock value, according to Morgan Stanley.
The firm estimates Best Buy’s push into the healthcare market could unlock $11 billion to $46 billion in potential revenues for the company, long-term.
“Best Buy is at the edge of a significant, untapped white space opportunity in healthcare,” Morgan Stanley’s equity analyst Simeon Gutman said in a note to clients Monday.
